Soros Fund Management’s Elevance Health ELV Stock Holding History

Soros Fund Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-157,600	Closed	-$20.7M	–	240
2016 Q2	$20.7M	Buy	+157,600	New	+$21.6M	0.44%	44

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Soros Fund Management's ELV Position: Q2 2016 in Review

Soros Fund Management sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 44,182 shares — an estimated $6.05M sold.

Soros Fund Management first reported a position in ELV in Q1 2014 and held it in 2 quarters. The position peaked at $11M in Q1 2014. 759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

Soros Fund Management reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
Soros Fund Management sold 44,182 Elevance Health shares in Q2 2016, an estimated $6.05M.
Soros Fund Management first reported a position in Elevance Health in Q1 2014 and held it in 2 quarters.
Soros Fund Management's Elevance Health position peaked at $11M in Q1 2014.
759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Soros Fund Management's 13F filing for Q2 2016, filed 15 Aug 2016.